6.43
price up icon1.26%   0.08
 
loading
Nyxoah Sa stock is traded at $6.43, with a volume of 79,929. It is up +1.26% in the last 24 hours and down -17.56% over the past month. Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
See More
Previous Close:
$6.35
Open:
$6.28
24h Volume:
79,929
Relative Volume:
0.85
Market Cap:
$245.99M
Revenue:
$4.71M
Net Income/Loss:
$-46.77M
P/E Ratio:
-3.8292
EPS:
-1.6792
Net Cash Flow:
$-60.34M
1W Performance:
+3.38%
1M Performance:
-17.56%
6M Performance:
-37.86%
1Y Performance:
-20.81%
1-Day Range:
Value
$6.28
$6.60
1-Week Range:
Value
$6.02
$6.85
52-Week Range:
Value
$5.55
$11.87

Nyxoah Sa Stock (NYXH) Company Profile

Name
Name
Nyxoah Sa
Name
Phone
-
Name
Address
-
Name
Employee
184
Name
Twitter
Name
Next Earnings Date
2025-08-18
Name
Latest SEC Filings
Name
NYXH's Discussions on Twitter

Compare NYXH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Instruments & Supplies icon
NYXH
Nyxoah Sa
6.43 245.99M 4.71M -46.77M -60.34M -1.6792
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
476.16 172.53B 9.15B 2.63B 1.99B 7.17
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
199.66 55.89B 21.39B 1.61B 2.55B 5.56
Medical Instruments & Supplies icon
ALC
Alcon Inc
82.02 43.59B 9.93B 1.12B 1.43B 2.26
Medical Instruments & Supplies icon
RMD
Resmed Inc
293.73 41.89B 5.15B 1.40B 1.65B 9.51
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
247.85 17.48B 2.96B 487.70M 344.00M 6.68

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-31-23 Initiated H.C. Wainwright Buy
Jul-19-23 Initiated Robert W. Baird Neutral
Apr-21-22 Initiated Oppenheimer Outperform
Apr-06-22 Initiated Wolfe Research Peer Perform
Dec-21-21 Resumed Cantor Fitzgerald Overweight
Jul-28-21 Initiated Cantor Fitzgerald Overweight
View All

Nyxoah Sa Stock (NYXH) Latest News

pulisher
Aug 20, 2025

Nyxoah sees Q2 revenue up 73%, plans R&D shift to U.S. and Belgium; shares rise - MSN

Aug 20, 2025
pulisher
Aug 20, 2025

Price Channel Expanding on Nyxoah SA’s Chart2025 EndofYear Setup & AI Powered Market Entry Strategies - classian.co.kr

Aug 20, 2025
pulisher
Aug 20, 2025

Nyxoah: The High-Risk High-Reward Medtech To Own (NASDAQ:NYXH) - Seeking Alpha

Aug 20, 2025
pulisher
Aug 20, 2025

Brainstorm Posts 43% EPS Gain in Q2 - AOL.com

Aug 20, 2025
pulisher
Aug 20, 2025

Oncology Institute Sales Jump 22 Percent - AOL.com

Aug 20, 2025
pulisher
Aug 20, 2025

Vivos Therapeutics Unveils New Model - AOL.com

Aug 20, 2025
pulisher
Aug 19, 2025

Medtronic Lifts Annual Outlook, Appoints New Directors In Post-Elliott Strategic Shift - AOL.com

Aug 19, 2025
pulisher
Aug 19, 2025

UroGen (URGN) Q2 Revenue Rises 11% - AOL.com

Aug 19, 2025
pulisher
Aug 19, 2025

Nyxoah total operating loss for Q2 2025 hits €19.9M - Medical Buyer

Aug 19, 2025
pulisher
Aug 19, 2025

Oppenheimer reiterates Outperform rating on Nyxoah stock with $13 target - Investing.com

Aug 19, 2025
pulisher
Aug 19, 2025

Stifel reiterates Buy rating on Nyxoah stock following FDA approval - Investing.com

Aug 19, 2025
pulisher
Aug 19, 2025

NewAmsterdam (NAMS) Q2 Revenue Jumps 49% - AOL.com

Aug 19, 2025
pulisher
Aug 18, 2025

Nyxoah’s Genio System Gains FDA Approval - TipRanks

Aug 18, 2025
pulisher
Aug 18, 2025

Nyxoah's FDA Approval and U.S. Launch of Genio System: A High-Conviction Play in the OSA Market? - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

Earnings call transcript: Nyxoah Q2 2025 sees stock rise post-earnings By Investing.com - Investing.com Nigeria

Aug 18, 2025
pulisher
Aug 18, 2025

Nyxoah Q2 Revenue Jumps 74 Percent - AOL.com

Aug 18, 2025
pulisher
Aug 18, 2025

NeuroPace Revenue Jumps 22 Percent in Q2 - AOL.com

Aug 18, 2025
pulisher
Aug 18, 2025

Nyxoah's Q2 2025: Unpacking Key Contradictions in Commercial Launch, Reimbursement, and Regulatory Strategies - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

Earnings call transcript: Nyxoah Q2 2025 sees stock rise post-earnings - Investing.com

Aug 18, 2025
pulisher
Aug 18, 2025

Nyxoah (NYXH) Q2 2025 Earnings Call Transcript - Mitrade

Aug 18, 2025
pulisher
Aug 18, 2025

Nyxoah Q2 2025 Earnings Call Transcript - MarketBeat

Aug 18, 2025
pulisher
Aug 18, 2025

Nyxoah Q2 Revenue Jumps 74 Percent - The Motley Fool

Aug 18, 2025
pulisher
Aug 18, 2025

Nyxoah Launches Genio System in U.S. Following FDA Approval - TipRanks

Aug 18, 2025
pulisher
Aug 18, 2025

Nyxoah SA reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 18, 2025
pulisher
Aug 18, 2025

Nyxoah Reports Second Quarter Financial and Operating Results - The Manila Times

Aug 18, 2025
pulisher
Aug 18, 2025

First-Ever Bilateral Sleep Apnea Neurostimulation Device: Nyxoah's Genio Gets FDA Green Light with 67% Efficacy - Stock Titan

Aug 18, 2025
pulisher
Aug 18, 2025

Nyxoah : Q2 Report 2025 - MarketScreener

Aug 18, 2025
pulisher
Aug 18, 2025

Can Traders Expect Breakout From Nyxoah SA This WeekJuly 2025 Market Mood & Weekly Top Gainers Alerts - newsimpact.co.kr

Aug 18, 2025
pulisher
Aug 18, 2025

Market reaction to Nyxoah SA’s recent newsBond Market & Capital Efficiency Focused Ideas - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Visualizing Nyxoah SA stock with heatmapsQuarterly Market Summary & Stepwise Swing Trade Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Will Nyxoah SA benefit from macro trendsPortfolio Update Summary & Risk Managed Trade Strategies - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

How to read the order book for Nyxoah SAPortfolio Gains Report & Verified Stock Trade Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Will Nyxoah SA be affected by tariffsTrade Signal Summary & Technical Analysis for Trade Confirmation - mustnews.co.kr

Aug 17, 2025
pulisher
Aug 16, 2025

Nyxoah SA stock momentum explained2025 Price Momentum & Weekly High Potential Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Using data filters to optimize entry into Nyxoah SA2025 Biggest Moves & Community Trade Idea Sharing Platform - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Will Nyxoah SA announce a stock splitJuly 2025 Technicals & AI Enhanced Market Trend Forecasts - thegnnews.com

Aug 15, 2025
pulisher
Aug 15, 2025

Smart tools for monitoring Nyxoah SA’s price actionTrade Exit Summary & Expert Curated Trade Ideas - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Adagio Medical Posts Narrower Q2 Loss - AOL.com

Aug 15, 2025
pulisher
Aug 15, 2025

Is Nyxoah SA forming a reversal patternWeekly Gains Report & Smart Swing Trading Techniques - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Nyxoah Secures FDA Approval for Innovative Sleep Apnea Treatment - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea - Yahoo Finance

Aug 15, 2025
pulisher
Aug 14, 2025

What drives Nyxoah SA’s stock priceQuarterly Trade Report & Verified Short-Term Plans - mustnews.co.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Nyxoah SA Uptrend in Early Stages Indicators Say YesWeekly Profit Recap & Real-Time Volume Triggers - newsyoung.net

Aug 14, 2025
pulisher
Aug 14, 2025

What’s the recovery path for long term holders of Nyxoah SAQuarterly Profit Review & AI Based Buy and Sell Signals - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Top chart patterns to watch in Nyxoah SAEarnings Risk Report & Detailed Earnings Play Alerts - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Verrica Posts Profit in Fiscal Q2 - AOL.com

Aug 13, 2025
pulisher
Aug 13, 2025

Adaptimmune Sales Jump 59 Percent - AOL.com

Aug 13, 2025
pulisher
Aug 12, 2025

Citius Oncology Beats Fiscal Q3 EPS - AOL.com

Aug 12, 2025
pulisher
Aug 12, 2025

When is the best time to buy Nyxoah SA stockWeekly Trade Review & Reliable Trade Execution Plans - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Nyxoah wins FDA approval for Genio OSA treatment - BioWorld MedTech

Aug 12, 2025
pulisher
Aug 12, 2025

Nyxoah Gains FDA Approval for Genio System, Reports 73% Revenue Increase in Q2 2025. - AInvest

Aug 12, 2025

Nyxoah Sa Stock (NYXH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$149.57
price up icon 6.33%
medical_instruments_supplies BAX
$24.54
price up icon 2.89%
$73.55
price up icon 2.15%
medical_instruments_supplies COO
$75.22
price up icon 2.98%
$68.26
price up icon 1.62%
medical_instruments_supplies WST
$247.85
price up icon 2.15%
Cap:     |  Volume (24h):